1. Home
  2. TG vs ALLO Comparison

TG vs ALLO Comparison

Compare TG & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TG
  • ALLO
  • Stock Information
  • Founded
  • TG 1988
  • ALLO 2017
  • Country
  • TG United States
  • ALLO United States
  • Employees
  • TG N/A
  • ALLO N/A
  • Industry
  • TG Metal Fabrications
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TG Industrials
  • ALLO Health Care
  • Exchange
  • TG Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • TG 301.0M
  • ALLO 252.9M
  • IPO Year
  • TG 1989
  • ALLO 2018
  • Fundamental
  • Price
  • TG $8.07
  • ALLO $1.18
  • Analyst Decision
  • TG
  • ALLO Strong Buy
  • Analyst Count
  • TG 0
  • ALLO 10
  • Target Price
  • TG N/A
  • ALLO $8.88
  • AVG Volume (30 Days)
  • TG 70.6K
  • ALLO 3.0M
  • Earning Date
  • TG 11-07-2025
  • ALLO 11-06-2025
  • Dividend Yield
  • TG N/A
  • ALLO N/A
  • EPS Growth
  • TG N/A
  • ALLO N/A
  • EPS
  • TG N/A
  • ALLO N/A
  • Revenue
  • TG $643,014,000.00
  • ALLO N/A
  • Revenue This Year
  • TG N/A
  • ALLO N/A
  • Revenue Next Year
  • TG N/A
  • ALLO $100.00
  • P/E Ratio
  • TG N/A
  • ALLO N/A
  • Revenue Growth
  • TG 28.10
  • ALLO N/A
  • 52 Week Low
  • TG $6.42
  • ALLO $0.86
  • 52 Week High
  • TG $9.43
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • TG 53.67
  • ALLO 53.74
  • Support Level
  • TG $8.01
  • ALLO $1.13
  • Resistance Level
  • TG $8.32
  • ALLO $1.21
  • Average True Range (ATR)
  • TG 0.19
  • ALLO 0.06
  • MACD
  • TG 0.07
  • ALLO 0.01
  • Stochastic Oscillator
  • TG 68.38
  • ALLO 80.53

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: